HPR Poster Präsentation und Konferenzteilnahme am 15. IASP Schmerzkongress in Buenos Aires 2014

FIRST CLINICAL TRANSLATION OF THE ANTI-NOCICEPTIVE/ANTI-HYPERALGESIC EFFICACY OF A T-TYPE CALCIUM CHANNEL MODULATOR (Z944) – USING LASER EVOKED POTENTIALS AND VAS IN UV-B AND CAPSAICIN IRRITATED SKIN IN HEALTHY HUMANS

Author Block: K. D. Schaffler Germany,Head, HPR-Human Pharmacodynamic Res., Munich; M. S. Lee, Res. & Translational Med., Zalicus Pharmaceuticals Ltd., Cambridge, MA, USA; M. Versavel, Zalicus Pharmaceuticals

Der IASP Kongress findet vom 6. – 11. Oktober, 2014 in Buenos Aires statt. Für einen Abstract sehen Sie bitte folgenden Link: HPR Abstract Buenos Aires.

About Klaus Schaffler

Dr. med. Klaus Schaffler (MD) has been specializing in the electrophysiology and pharmacology of the human central nervous system (CNS) – as well as in the field of human experimental pain research. During this development process, HPR Dr. Schaffler GmbH has issued over 175 presentations/ publications (sharing more than 50 on pain/ analgesia) and has conducted more than 150 phase-I studies with quite different objectives.
This entry was posted in Klinische Studien. Bookmark the permalink.